Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics

Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics

Bibliographic Details
Main Authors: Shane M Devlin, Brian Bressler, Charles N Bernstein, Richard N Fedorak, Alain Bitton, Harminder Singh, Brian G Feagan
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2013/327120
id doaj-fde7be446553447e99c8ca7273367e7f
record_format Article
spelling doaj-fde7be446553447e99c8ca7273367e7f2020-11-24T23:13:29ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002013-01-01271056757110.1155/2013/327120Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry BiologicsShane M Devlin0Brian Bressler1Charles N Bernstein2Richard N Fedorak3Alain Bitton4Harminder Singh5Brian G Feagan6Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, CanadaUniversity of British Columbia, Vancouver, British Columbia, CanadaIBD Clinical and Research Centre and Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, McGill University Health Centre, Montreal, Quebec, CanadaIBD Clinical and Research Centre and Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, CanadaRobarts Clinical Trials, Robarts Research Institute, and Department of Medicine and Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canadahttp://dx.doi.org/10.1155/2013/327120
collection DOAJ
language English
format Article
sources DOAJ
author Shane M Devlin
Brian Bressler
Charles N Bernstein
Richard N Fedorak
Alain Bitton
Harminder Singh
Brian G Feagan
spellingShingle Shane M Devlin
Brian Bressler
Charles N Bernstein
Richard N Fedorak
Alain Bitton
Harminder Singh
Brian G Feagan
Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
Canadian Journal of Gastroenterology
author_facet Shane M Devlin
Brian Bressler
Charles N Bernstein
Richard N Fedorak
Alain Bitton
Harminder Singh
Brian G Feagan
author_sort Shane M Devlin
title Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
title_short Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
title_full Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
title_fullStr Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
title_full_unstemmed Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
title_sort overview of subsequent entry biologics for the management of inflammatory bowel disease and canadian association of gastroenterology position statement on subsequent entry biologics
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2013-01-01
url http://dx.doi.org/10.1155/2013/327120
work_keys_str_mv AT shanemdevlin overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT brianbressler overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT charlesnbernstein overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT richardnfedorak overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT alainbitton overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT harmindersingh overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
AT briangfeagan overviewofsubsequententrybiologicsforthemanagementofinflammatoryboweldiseaseandcanadianassociationofgastroenterologypositionstatementonsubsequententrybiologics
_version_ 1725598218659561472

Similar Items